Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: A review of 272 cases

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 46, Issue 6, 2006, Pages 479-485

  Rose, Sally B ^a   Shand, Carol ^b,c   Simmons, Ann ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b WELLINGTON HOSPITAL   (New Zealand)

^c NONE   (New Zealand)

Author keywords

Abortion; Mid trimester medical induction; Mifepristone; Misoprostol

Indexed keywords

ANTIBIOTIC AGENT; ERGOMETRINE PLUS OXYTOCIN; FENTANYL; MIFEPRISTONE; MISOPROSTOL; NARCOTIC AGENT; OXYTOCIN; PETHIDINE; PROSTAGLANDIN F2 ALPHA;

ADOLESCENT; ADULT; AGE; ANALGESIA; BACTERIAL INFECTION; BLEEDING; BLOOD TRANSFUSION; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; DATA BASE; DRUG USE; ETHNOLOGY; FEMALE; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; INFORMATION PROCESSING; LABOR INDUCTION; LABOR PAIN; MAJOR CLINICAL STUDY; MEDICAL AUDIT; OBSTETRIC OPERATION; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL; PUBLISHING; RETAINED PLACENTA; REVIEW; SECOND TRIMESTER PREGNANCY; STATISTICAL ANALYSIS;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADOLESCENT; ADULT; FEMALE; HUMANS; MEDICAL AUDIT; MIFEPRISTONE; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES;

EID: 33751117190     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2006.00646.x     Document Type: Review

References (28)

1. Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM. Midtrimester medical termination of pregnancy: A review of 1002 consecutive cases. Contraception 2004; 69: 51.
2. Abortion Supervisory Committee. Report of the Abortion Supervisory Committee 2005. Presented to the House of Representatives pursuant to Section 39 of the Contraception, Sterilisation and Abortion Act 1977. New Zealand.
3. Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion. Evidence-based clinical guideline no. 7. London: Royal College of Obstetricians and Gynaecologists, 2004.
4. Boyd PA, Tondi F, Hicks NR, Chamberlain PF. Autopsy after termination of pregnancy for fetal anomaly: Retrospective cohort study. BMJ 2004; 328: 137-140.
5. Sparrow M. The introduction of mifepristone into New Zealand. Venereology 2001; 14: 143-147.
6. Sparrow M. Introducing mifepristone into New Zealand. Obstet Gynecol 2004; 6: 145-146.
7. Urquhart DR, Bahzad C, Templeton AA. Efficacy of the antiprogestin mifepristone (RU 486) prior to prostaglandin termination of pregnancy. Hum Reprod 1989; 4: 202-203.
8. Rodger MW, Baird DT. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol 1990; 97: 41-45.
9. Urquhart DR, Templeton AA. The use of mifepristone prior to prostaglandin-induced mid-trimester abortion. Hum Reprod 1990; 5: 883-886.
10. Thong KJ, Baird DT. Induction of second trimester abortion with mifepristone and gemeprost. Br J Obstet Gynaecol 1993; 100: 758-761.
11. Webster D, Penney GC, Templeton A. A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol. Br J Obstet Gynaecol 1996; 103: 706-709.
12. World Health Organization, Task Force on Post-ovulatory Methods of Fertility Regulation. Termination of pregnancy with reduced doses of mifepristone. Br Med J 1993; 307: 532-537.
13. Bartley J, Baird DT. A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy. BJOG 2002; 109: 1290-1294.
14. El-Refaey H, Hinshaw K, Templeton A. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486). Hum Reprod 1993; 8: 1744-1746.
15. Ngai SW, Tang OS, Ho PC. Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3.h) misoprostol when combined with mifepristone in termination of second trimester pregnancy. Hum Reprod 2000; 15: 2205-2208.
16. Tang OS, Chan CCW, Kan AS, Chung Ho P. A prospective randomised comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation. Hum Reprod 2005; 20: 3062-3066.
17. Ho PC, Ngai SW, Liu KL, Wong GC, Lee SW. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstet Gynecol 1997; 90: 735-738.
18. el-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995; 332: 983-987.
19. el-Refaey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: A randomized comparison between two misoprostol regimens. Hum Reprod 1995; 10: 475-478.
20. Ho PC, Chan YF, Lau W. Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: A randomised comparative trial. Contraception 1996; 53: 281-283.
21. Jain JK, Mishell DR Jr. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy. N Engl J Med 1994; 33: 290-293.
22. Shand C, Rose S, Simmons A, Sparrow M. Introduction of early medical abortion in New Zealand: An audit of the first 67 cases. Aust NZ J Obstet Gynaecol 2005; 45: 316-320.
23. Ashok PW, Templeton A. Nonsurgical mid-trimester termination of pregnancy: A review of 500 consecutive cases. Br J Obstet Gynaecol 1999; 106: 706-710.
24. Goh SETK. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: A review of 386 consecutive cases. Contraception 2006; 73: 516-519.
25. Grimes DA, Smith MS, Witham AD. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: A pilot randomised controlled trial. BJOG: Int J Obstet Gynaecol 2004; 111: 148-153.
26. Dickinson JE, Evans SF. A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality. Obstet Gynecol 2003; 101: 1294-1299.
27. Langer BR, Peter C, Firtion C, David E, Haberstich R. Second and third medical termination of pregnancy with misoprostol without mifepristone. Fetal Diagn Ther 2004; 19: 266-270.
28. Dickinson JE, Evans SF. The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. Am J Obstet Gynecol 2002; 186: 470-474.